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Background: Helicobacter pylori infects half of the world’s population and causes
gastric cancer in a subset of infected adults. Previous blood microarray findings showed
that apparently healthy children, persistently infected with H. pylori have differential
gene expression compared to age-matched, non-infected children. SLC5A8, a cancer
suppressor gene with decreased expression among infected children, was chosen for
further study based on bioinformatics analysis.
Methods: A pilot study was conducted using specific qRT-PCR amplification of SLC5A8
in blood samples from H. pylori infected and non-infected children, followed by a larger,
blinded, case-control study. We then analyzed gastric tissue from H. pylori infected and
non-infected children undergoing endoscopy for clinical purposes.
Results: Demographics, clinical findings, and family history were similar between
groups. SLC5A8 expression was decreased in infected vs. non-infected children
in blood, 0.12 (IQR: 0–0.89) vs. 1.86 (IQR: 0–8.94, P = 0.002), and in gastric tissue,
0.08 (IQR: 0.04–0.15) vs. 1.88 (IQR: 0.55–2.56; P = 0.001). Children who were
both stool positive and seropositive for H. pylori had the lowest SLC5A8 expression
levels.
Conclusions: H. pylori infection is associated with suppression of SCL5A8, a cancer
suppressor gene, in both blood and tissue samples from young children.
Key Points: Young children, persistently infected with Helicobacter pylori show
decreased expression of SLC5A8 mRNA in both blood and tissue samples as compared
to non-infected children.
Keywords: Helicobacter pylori, persistent infection, children, SLC5A8, cancer suppressor gene, qPCR detection
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INTRODUCTION
Helicobacter pylori (H. pylori) is a Gram-negative bacillus that
infects half of the world’s population and causes gastric cancer
in a subset of infected adults (Malaty, 2007). According to a
“National Health Survey” performed in Chile in 2003, the H.
pylori seroprevalence rate in adults 17 years of age and older is
73% (Minsal, 2004).
H. pylori can be acquired during the first year of life, especially
in populations living in lower socioeconomic environments,
although information on childhood infection is scarce (Daugule
and Rowland, 2008; Jaime et al., 2013; O’Ryan et al., 2013, 2015).
We previously reported that 20–25% of children under 5 years
of age from a semi-rural area of Chile are persistently infected
with H. pylori, based on prolonged detection of antigen in stools
(O’Ryan et al., 2013, 2015). Most persistently infected children
do not present signs or symptoms during early childhood; to
date, only 2/50 children followed up until a median age of 5
years and 10 months (range: 2 years 6month–8 years10 momth)
have presented abdominal complaints. Comparing whole blood
microarray data from infected children with non-infected, age-
matched controls we identified differential expression of nearly
100 genes (O’Ryan et al., 2015). Based on bioinformatics
analysis and gene characterization, and specifically because of its
association with cancer, we targeted the gene SLC5A8 for further
study.
SLC5A8 is a monocarboxylate transporter located in several
tissues and organs, including the gastrointestinal tract (Zhang
et al., 2010; Brim et al., 2011). This gene encodes a
transmembrane protein that facilitates entrance of butyrate,
propionate, and other short-chain fatty acids into normal cells.
Incorporation of butyrate into tumor cells of both gastric
and colon cancers favors tumor suppression by inhibiting
inflammation, promoting cell differentiation, stimulating cell
cycle arrest, and inducing apoptosis (Elangovan et al., 2013;
Park et al., 2013; Gurav et al., 2015). Ueno et al. demonstrated
that SLC5A8 was downregulated in adults with gastric cancer
(Ueno et al., 2004) and was silenced in ∼60% of individuals
with colorectal cancer (Keenan and Frizelle, 2014), and others
have confirmed that it is downregulated in several cancer
types, including stomach (Ueno et al., 2004; Ganapathy et al.,
2008), colon (Li et al., 2003; Miyauchi et al., 2004; Thangaraju
et al., 2008), thyroid (Ganapathy et al., 2005; Porra et al.,
2005; Schagdarsurengin et al., 2006), and breast (Thangaraju
et al., 2006, 2009; Coothankandaswamy et al., 2013; Elangovan
et al., 2013). Silencing has also been observed in earlier
stages of cancer, including, colonic adenomas and colonic-
crypts (Li et al., 2003). Although decreased SLC5A8 expression
has been reported among individuals with gastric cancer,
it has not been directly associated with H. pylori infection
in adults or in children with symptomatic or asymptomatic
infection.
The aim of this study was to confirm and expand on our
blood microarray findings by determining if SLC5A8 expression
levels are decreased in asymptomatic as well as symptomatic
children infected with H. pylori compared to non-infected
children.
METHODS
Bioinformatics Selection of the Gene
SLC5A8
We previously performed microarray analysis on blood samples
from persistently, transiently and non-H. pylori infected children
(O’Ryan et al., 2015). Further analysis of persistent compared to
non-infected children identified 97 differentially expressed genes
(Supplementary Table 2). These 97 genes were then classified
by biological function using DAVID tools and by function and
associated disease using the IPA R© system (Huang et al., 2009;
Krämer et al., 2014).
Based on analysis with DAVID tools, we selected 20 genes
belonging to the three clusters with the highest scores (Figure 1,
Supplementary Tables 3, 4). Additionally, 26 genes from one
cluster associated with cancer were selected based on analysis
with the IPA R© system (Supplementary Table 5). Ten of
these 36 genes overlapped (Figure 1B). A literature review
focusing on cancer and H. pylori was performed for these
10 genes (see Supplementary Material for more details). This
review indicated that eight genes are associated with cancer
progression.
SLC5A8 was selected because it was recently identified as
a cancer suppressor gene and because previous studies related
downregulation of this gene to the progression of various types
of cancer, including gastric (Ueno et al., 2004), colonic (Li et al.,
2003; Thangaraju et al., 2008; Brim et al., 2011), thyroid (Porra
et al., 2005), and breast cancers (Foglietta et al., 2014).
FIGURE 1 | Identification of the target gene, SLC5A8, using different
bioinformatics tools. (A) Scheme describing the bioinformatics pathway
used to select our target gene; (B) Venn diagram of those genes identified by
both Ingenuity and DAVID tools.
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Study Design, Recruitment, and H. pylori
Detection
Recruitment, blood sample, and data collection for the healthy
child cohort as well as informed consent were approved
by the Comité de Etica de Investigación, Servicio de Salud
Metropolitano Norte and by the Comité de Etica, Universidad de
Chile. Recruitment, tissue sample and data collection for children
undergoing endoscopy was approved by the Comité de Etica de
Investigación, Pontificia Universidad Católica (Project #PUC12-
236). For the healthy child cohort, children were categorized as
having a persistent H. pylori infection if they had three or more
stool samples (obtained every 3–4months) consecutively positive
forH. pylori by ELISA over several years of follow up (median age
of follow-up: 5 years 10 months, range: 2 years 6 month–8 years
10 month) (O’Ryan et al., 2013, 2015). Non-infected children
were those whose stool samples were never positive for H. pylori
by ELISA during the follow-up period.
Blood samples H. pylori persistently infected and non-infected
children were matched by age, gender, and city. One milliliter of
blood was obtained from all children by venipuncture, stored in
Tempus blood RNA tubes (Thermo Fisher Scientific N◦4342792)
and transported to the laboratory following the appropriate cold
chain protocols for gene expression assays.
We analyzed blood samples from children in our ongoing
child cohorts, all of whom had been previously consented for a
pilot study and a larger case-control study. For the pilot study,
we randomly selected 16 blood samples from children under 5
years of age that had been previously analyzed by microarray
(O’Ryan et al., 2015). For the blind, case-control study, 50
persistent and 44 non-infected children were selected (see
Supplementary Material and Figure 2). The laboratory staff was
blind to H. pylori infection status. H. pylori was detected by stool
ELISA (O’Ryan et al., 2013, 2015) using the commercial ELISA
Premier Platinum HpSA monoclonal antibody kit (Meridian
Bioscience, Ohio, USA). All samples positive for 16S rRNA were
tested for the presence of CagA by qRT-PCR, as described in the
Supplementary Material.
Stool samples were obtained every 3 or 4 months and
transported, following appropriate cold chain protocols, to our
laboratory for detection of H. pylori antigen by ELISA. Stool
samples were stored at −80◦C. Bacterial DNA was extracted
using the QIAamp DNA stool kit (Qiagen, Hilden, Germany)
following manufacturer’s instructions, with an additional bead-
beating step to increase the yield of purified DNA. Detection
of 16S rRNA and cagA was performed using previously
described primers (O’Ryan et al., 2015) (Supplementary Table 1).
Amplification was performed in a reaction volume of 20 µL with
Fast EvaGreen dye qPCR master mix (Biotium, Hayward. CA)
with 4 µl of total purified DNA from each stool sample. The
PCR reaction was performed using a STEP ONE thermocycler R©
(Applied Biosystems, Foster City, CA). A three-step PCR
was used followed by melting curve analysis. Strain ATCC
43504 was used as the positive control. Amplification of total
bacterial 16S rRNA gene was performed using an in-house
PCR, in order to identify samples with possible PCR inhibitors.
Each sample was analyzed in duplicate within each qRT-PCR
reaction.
H. pylori Detection in Gastric Tissue
Gastric samples were analyzed from 24 patients, 5–12 years
of age, who underwent endoscopy due to symptoms such as
abdominal pain, vomiting, and/or diarrhea. All patients answered
a clinical questionnaire that included age, gender, and relevant
clinical data. Informed consent was obtained from the patient’s
parents or legal guardians. Upper gastrointestinal endoscopy was
performed in the Hospital Clínico UC CHRISTUS and stored
at −80◦C in the Department of Pediatric Gastroenterology and
Nutrition, School of Medicine, Pontificia Universidad Católica
de Chile. Three biopsies were obtained from the gastric antrum,
one for Rapid Urease Test (Hepytest R©, BiosChile, Santiago,
Chile), one for histological staining of H. pylori and one for
mRNA extraction and SLC5A8 expression analysis. A patient was
considered infected with H. pylori if both urease and histology
staining were positive.
H. pylori Serology
A commercial ELISA kit for anti-H. pylori antibodies was used
to analyze serum samples according to the manufacturer’s
instructions (Premier R© H. pylori; Meridian Bioscience,
Cincinnati, Ohio, USA), as previously described (O’Ryan
et al., 2015).
SLC5A8 Gene Expression Assay in Blood
and Tissue
RNA was extracted from blood using the QIAamp RNA
Blood Mini Kit (ID: 52304, Qiagen, Hilden, Germany). It was
then treated with DNases using the TURBO DNA-FreeTM Kit
(AM1907 AMBION, Thermo Fisher Scientific. Oklahoma, USA)
and quantified using NanoQuant Take3 equipment. cDNA was
obtained using the ImProm-IITM Reverse Transcription System
(ID: A3800, Promega, Madison, Wisconsin, USA).
Endoscopic biopsies were frozen in liquid nitrogen
immediately upon sampling and stored at −80◦C until
analysis. Total RNA was extracted using the RNAeasy kit
(Qiagen; Hilden, Germany) and quantified using NanoQuant
Take3 equipment. Reverse transcription was performed in a
minimum of 1 µg total RNA; integrity was revised in 1% agarose
gel using a commercial kit (AffinityScript QPCR cDNA synthesis
kit, Agilent Technologies; Santa Clara, California, USA). A mix
of DT oligos and random primers was used for the synthesis of
cDNA.
Taqman R© probes (Applied Biosystems, Foster City,
California, USA) were used for the qPCR gene expression assay.
Expression of SLC5A8 was normalized to the housekeeping
gene β-actin and expression levels are reported using the 21CT
quantification method (Rao et al., 2013). qRT-PCR assays were
performed in a STEP ONE thermocycler R© (Applied Biosystems,
Foster City, CA). A gastric tissue sample that expressed SLC5A8
was used as a positive control; non-reverse transcription RNA
and water were used as negative controls. All samples were
analyzed in three independent experiments; in each experiment
we ran the samples in duplicate (in order to obtain one valid
value). The average of the values from the three experiments was
used for analysis.
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FIGURE 2 | Flow diagram of study patients. The asymptomatic cohort is comprised of children under 5 years old, and the symptomatic cohort children under 12
years old. Some children from the asymptomatic cohort were included in both the bioinformatics analysis and the pilot/blinded-study, but all these samples were
reprocessed within their respective studies.
Statistical Analysis
Statistical analysis was performed using R Version 3.0.0
(R Development Core Team, 2013). For categorical variables,
groups were compared using the Chi-squared test; the Kruskal–
Wallis test was used for continuous, non-normal variables. P-
values ≤ 0.05 were considered significant.
RESULTS
Expression of SLC5A8 is Decreased in
Blood Samples from Infected Compared
with Non-Infected Children
Pilot Study
We performed quantitative reverse transcription PCR (qRT-
PCR) for SLC5A8 and β-Actin on blood samples from nine
infected and seven non-infected children (for definitions see
Supplementary Material). Overall, persistently infected children
had lower levels of SLC5A8mRNA (0.03; IQR 0–0.08), compared
to non-infected children (3.17; IQR 0.57–4.88; P = 0.050;
Figure 3A). Similarly, we compared the median expression of
each group observing an approximately 120-fold decrease in
expression in infected children compared with non-infected
children.
Blinded Case-Control Study of SLC5A8 Expression in
Blood Samples
We blindly analyzed 94 blood samples, 50 from H. pylori
infected and 44 from non-infected children. There were no
statistically significant differences between infected and non-
infected children in demographic variables, family and past
medical history, medication use and gastric symptomatology
(Table 1). SLC5A8 expression was decreased in the infected
(0.12; IQR 0–0.89) compared to the non-infected group (1.86;
IQR 0–8.94; P = 0.002; Figure 3B). Similarly, a significant
difference was observed when we categorized expression levels
using a cutoff of <2 (<2 and >1) and (≤1) (Table 2; P =
0.008). The comparison of the median expression levels of each
group revealed a 5-fold decrease in infected vs. non-infected
children.
It is worth also mentioning that there were samples
in which expression levels were not detectable, 12 infected
and 4 non-infected children. We decided to include these
samples as part of the analysis, assigning them an expression
value of 0. However, even when excluding these samples
from the analysis the relationship remains significant (non-
infected: 2.92, IQR 0.72–10.84 vs. infected: 0.44, IQR 0.03–2.17:
P = 0.005).
In addition to stool antigen detection, we compared
mRNA SLC5A8 in a subset of children with differing anti-
H. pylori serology status. Out of 50 stool ELISA positive
children, 40 were seropositive for H. pylori (80%), whereas
4/33 (12%) stool ELISA negative children were seropositive
(P < 0.001; 11 non-infected children do not have serology
results available). For H. pylori infected seropositive children
median SLC5A8 expression levels were 0.04 (IQR: 0–0.79)
vs. 1.81 (IQR: 0.36–8.74) for non-infected seronegative
children (P = 0.002; Figure 3C). A comparison of the
median expression levels revealed a 5-fold decrease in
infected/seropositive compared to non-infected/seronegative
children.
Real time PCR (qRT-PCR) 16SrRNA amplification was
performed on one stool sample per persistent child in order to
confirm ELISA positive results; 46/50 samples were confirmed.
These samples were then analyzed by qRT-PCR for the CagA
virulence gene. No significant difference in SLC5A8 expression
was observed between CagA positive, (n= 22, 0.20; IQR: 0–0.88)
or negative children (n = 24, 0.05 IQR: 0–1.37; P = NS)
suggesting the lack of a consistent relationship between SLC5A8
expression and infection with a CagA positive or negative
H. pylori strains (Figure 3D).
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FIGURE 3 | SLC5A8 expression is decreased in blood samples from infected compared with non-infected children. All four panels show a dot plot
overlying a boxplot (showing the median and IQR; points outside the whisker lines are considered outliers, as specified by Turkey’s Test). Summary statistics are
shown below each panel. (A) mRNA SLC5A8 expression is significantly decreased in blood samples from H. pylori infected compared to non-infected children in the
pilot study (Kruskal–Wallis test, P = 0.050). (B) In a blinded case-control study of SLC5A8 expression in blood samples, expression levels are significantly decreased
in infected compared to non-infected children (Kruskal–Wallis test, P = 0.002). Four outliers were not shown for space (infected: 42; non-infected: 72, 212, 379). (C)
mRNA SLC5A8 expression is decreased in infected and H. pylori seropositive children vs. non-infected, seronegative children (Kruskal–Wallis test, P = 0.002). One
outlier was not shown for space (non-infected/seronegative: 378.51) (D) mRNA SLC5A8 expression does not differ (based on the Kruskal–Wallis test) between CagA
positive and negative children. One outlier was not shown for space (CagA positive: 42.03).
SLC5A8 Expression is Decreased in Tissue
Samples of H. pylori Infected Compared to
Non-Infected Children
Blinded Case-Control Study of SLC5A8 Expression in
Gastric Biopsies of H. pylori Infected and
Non-Infected Children
We analyzed gastric tissue from 12 H. pylori infected (as
determined by positive rapid urease test and histology staining)
and 12 non-infected children under 10 years of age who
underwent endoscopy due to abdominal complaints. There
were no significant differences in demographic characteristics
or gastric symptomatology between groups (Table 3). SLC5A8
mRNA was significantly lower in infected (0.08; IQR: 0.04–0.15)
compared to non-infected children (1.88; IQR: 0.55–2.56; P =
0.001; Figure 4). The difference in the median expression of each
group revealed a 24-fold decrease among infected compared to
non-infected children.
Histological information was available in 20 of the 24
children with tissue samples. A pathologist determined the
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TABLE 1 | Demographic, clinical, and family characteristics of children
enrolled in the case-control study according to H. pylori status.
H. pylori status
Non-infected Infected
Characteristic, N (%)A N = 44 N = 50
Male 25 (57) 29 (58)
Age (months), median (IQR) 63 (25–91) 63 (24–99)
Attended day care prior to age 2 13 (30) 16 (32)
Attended day care prior to age 4 13 (30) 10 (20)
Treated with Omeprazole 0/41 (0) 1/46 (2)
Family history of H. pylori 7 (16) 3 (6)
Family history of gastric cancer 9 (20) 6 (12)
Family history of gastric ulcer 13 (30) 15 (30)
None of the listed characteristics were significantly different between the two groups.
Aunless otherwise noted.
TABLE 2 | Distribution of SLC5A8 expression levels in H. pylori infected
and non-infected children.
Number (%) of subjects with indicated expression level according to
H. pylori infection status
Non-infected Infected
Expression level N = 44 N = 50
> 2 26 (59) 12 (24)
≤2 and >1 6 (14) 19 (38)
≤1 12 (27) 19 (38)
P = 0.008 by Chi-squared test.
degree of gastric damage, inflammatory activity, presence of
lymphoid follicles, and the presence or absence of gastric atrophy
(Supplementary Table 6). The higher the score, the greater the
gastric damage, and inflammatory processes; the score is based on
a scale of 0 (no damage), 1 (mild damage), 2 (moderate damage)
to 3 (severe damage). Symptoms, such as vomiting, recurrent
abdominal pain, were also scored by the treating physicians as
low,moderate and severe. Information on symptomdurationwas
grossly classified as occurring only during the previous week, for
at least a month, or for at least 1 year.
We analyzed each indicator of gastric damage and
symptomatology (inflammatory activity, gastritis, lymphoid
follicles, atrophy, symptoms and duration of symptoms). More
severe gastritis (P = 0.019), and presence of lymphoid follicles
(P = 0.044) were significantly associated with decreased SLC5A8
expression levels (Supplementary Figures 1, 2). The following
variables did not show a significant association with expression
levels: Inflammatory activity (P = 0.150), atrophy (P = 0.603),
symptoms (P = 0.872) (Supplementary Figures 3–5) and
symptom duration (P = 0.505).
Importantly, SLC5A8 expression levels were significantly
lower among infected children compared to non-infected with
similar conditions of inflammatory activity, lymphoid follicles,
and atrophy. Expression was lower for similar levels of gastritis,
but differences were not significant (Table 4).
TABLE 3 | Demographic, symptomatology, and gastric biopsy results of
infected and non-infected children undergoing endoscopy.
H. pylori status
Non-infected Infected P-value
Characteristic, N (%) N = 12 N = 12
Male 7 (29) 5 (21) NS
Age in years, median (IQR) 12.5 (5–17) 12 (8–14) NS
Body Mass Index 20.1 (16.2–23.9) 21.3 (13.9–31.2) NS
SYMPTOM SEVERITY
No symptom 0 1 NS
Mild 4 (33) 1 NS
Moderate 5 (42) 4 (33) NS
Severe 3 (25) 6 (50) NS
SYMPTOMS DURATION
1 week 7 (58) 5 (46) NS
1 month 3 (25) 4 (36) NS
1 year 2 (17) 2 (18) NS
UPPER GI ENDOSCOPY REPORT
Normal 5 (42) 0 0.016
Gastropathy 3 (25) 0 0.064
Nodules 4 (33) 12 (100) <0.001
HISTOLOGY REPORT*
Gastritis
Absence 6 (55) 0 NS
Mild 5 (45) 5 (55) NS
Moderate 0 4 (45) 0.011
Inflammatory activity
Absence 11 (100) 4 (45) NS
Presence 0 5 (55) 0.08
Lymphoid follicles
Presence 0 2 (22) NS
Absence 11 (100) 7 (78) NS
Atrophy
Presence 1 0 NS
Absence 10 (91) 9 (100) NS
*data available for 20 subjects.
DISCUSSION
In two separate evaluations, a pilot study and a case-control
study, median SLC5A8 expression levels were decreased in blood
samples from H. pylori infected children less than 6 years of
age as compared to non-infected children. This finding was
also confirmed in gastric tissue of infected compared to non-
infected children. H. pylori modulation of gene expression has
been demonstrated previously in adult populations (Hanada
and Graham, 2014; Obayashi et al., 2015); however, this is the
first report of a significant association between SLC5A8 gene
expression and H. pylori infection in both symptomatic and
asymptomatic children.
The fact that SLC5A8 expression is reduced in fresh whole
blood samples (which include several components such as
plasma, red blood cells, white blood cells, and platelets) from
H. pylori infected children raises several hypotheses as to how
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an infection occurring at the gastric level is affecting the
circulatory system. Extracellular vesicles (EVs), which carry
mRNAs, noncoding RNA and proteins generated from different
biological processes may play a role (EL Andaloussi et al., 2013;
Vader et al., 2014). EVs are membrane-enclosed structures that
are released into the surrounding environment by nearly all cell
FIGURE 4 | SLC5A8 expression is decreased in H. pylori infected
compared to non-infected children in gastric tissue samples
(Kruskal–Wallis test, P = 0.001). The plot is composed of a dot plot
overlying a boxplot (showing the median and IQR; points outside the whisker
lines are considered outliers, as specified by Turkey’s Test); summary statistics
are shown beneath the graph.
types. After separation from the plasmamembrane, these vesicles
may travel from the extracellular/intracellular space of gastric
epithelial cells into the blood stream (Vader et al., 2014). A second
hypothesis is that lymphocytes, neutrophils, and macrophages
present during an epithelial inflammatory event can be detected
in circulating blood (Cadamuro et al., 2014). This would require
a peripheral inflammatory environment during chronicH. pylori
infection, including the presence of macrophages capable of
storing genetic information detectable in blood (Fehlings et al.,
2012).
Our findings pose several questions and open several areas
for future research. Reduced SLC5A8 expression associated with
H. pylori infection at such an early age may be sustained over
time or may be transitory or fluctuating in association with
various factors. There was no correlation between expression
levels and a child’s age (data not shown). Expectedly, H. pylori
was associated with more severe gastric tissue damage, and
more severe damage (gastritis severity and presence of lymphoid
follicles) was associated with decreased SLC5A8 expression levels.
Importantly although, in children with similar levels of gastric
damage, infection was significantly associated with decreased
expression, strongly suggesting that infection is the key player
in this effect. Of note is that expression is reduced among
infected vs. non-infected children overall, but individually many
non-infected children had very low expression levels. Whether
infection plays a role in gene expression in only a subset of
children, and if these children are possibly at higher risk for
cancer occurrence decades later will require long-term cohort
monitoring and/or cross-sectional studies in different age groups.
We did not find an association between SLC5A8 expression
levels and the presence of CagA among infected individuals.
CagA amplification in stools is difficult (O’Ryan et al., 2013), and
although each sample was tested repeatedly before attributing
a positive or negative status, there remains some degree of
TABLE 4 | mRNA SLC5A8 expression in 11 infected and 9 non-infected children according to levels of histological damage.
Median (IQR) of indicated variable by H. pylori status
Infected Non-infected P-value
Gastritis (N) (N)
Normal 0 NS 6 1.80 (1.21–2.19)
Mild 5 0.29 (0.20–0.45) 5 1.94 (1.06–3.74) 0.34
Moderate 4 0.07 (0,02–0.07) 0 NS
Severe 0 NS 0 NS
Inflammatory activity
Presence 5 0.10 (0.09–0.37) 0 NS
Absence 4 0.06 (0.02–0.10) 11 2.00 (0.35–3.64) 0.03
Lymphoid Follicles
Presence 2 0.0254 (0.025–0.026) 0 NS
Absence 7 0,20 (0,09–0,45) 11 1.88 (0.55–2.60) 0.016
Atrophy
Presence 0 NS 1 1,81
Absence 9 0.10 (0.06–0.29) 10 1.94 (0.35–3.74) 0.01
+NS: No subjects in this category.
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uncertainty based on the fact that we were attempting to detect
a virulence factor present in H. pylori at the gastric level in stool
samples. Obtaining theH. pylori strain directly from the stomach
would be ideal, but ethically not feasible for apparently healthy
children; unfortunately, there has been little success in culturing
this bacteria from stool samples (O’Ryan et al., 2013, 2015). In
addition, it is possible that persistent infections may be caused
by different strains over time, making our results, based on one
sample, inconclusive.
At this point, it might be interesting to speculate on how
reduced SLC5A8 expression in host cells may benefit H. pylori.
Indeed, this pathogen has been shown to modulate host gene
expression in ways that favor host infection (Matsushima et al.,
2011; Kim et al., 2012; Hanada and Graham, 2014; O’Ryan
et al., 2015; Rossi et al., 2016). As mentioned in this manuscript,
SLC5A8 is implicated in the control of short-chain fatty acid
uptake, which in turn modulates the expression of cell cycle
control and pro-inflammatory genes. Potentially, therefore, one
may speculate that loss of SLC5A8 expression induced by H.
pylori should promote cell proliferation and inflammation, which
in turn could favor the infection process and enhance severity of
the infection.
There are limitations to this study. The number of tissue
samples analyzed is relatively small and we were not able to
analyze blood and tissue from the same children due to lack of
dual samples. For healthy children who provided blood samples,
it was not ethical to request an endoscopy and tissue biopsy due
to their lack of symptoms; for children providing a tissue sample
due to symptoms as part of another study, collection of a blood
sample was not contemplated at the time of original study design.
Histological information was unavailable for 4 children providing
gastric biopsy samples, and the standardized Sydney Score was
not initially considered, so a less conventional evaluation of
gastric damage severity was used. Lastly, we only analyzed one
of the genes identified by gene wide array; analysis of additional
genes in light of our findings, represent a new challenge.
Future prospective studies should focus on culturingH. pylori
strains in both children and adults requiring endoscopy, with
different stages of gastric pathology, in order to confirm
differences in SLC5A8 expression levels. In addition, longitudinal
studies of infected children, including gene expression levels
over time, will be required to determine the co-occurrence
of persistent infection and decreased gene expression levels.
Importantly, studies using in vitromodels, including different cell
lines, will be required to understand the mechanisms involved in
reduced gene expression.
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